FOLD Q2 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$81M+4.3% YoY

Gross Profit

$73M89.8% margin

Operating Income

-$61M-75.1% margin

Net Income

-$62M-77.0% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$801M

Total Liabilities

$627M

Stockholders' Equity

$173M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$77M	+4.3%
Gross Profit	$73M	$69M	+5.1%
Operating Income	-$61M	-$39M	-56.1%
Net Income	-$62M	-$51M	-21.3%

Geographic Segments

Non-US

$53M66%

UNITED STATES

$28M34%